Font Size: a A A

Clinical Study On The Effect Of Qianjinweijing Decoction And Shengmai Powder On Postoperative Rehabilitation Of Non-small Cell Lung Cancer

Posted on:2020-11-25Degree:MasterType:Thesis
Country:ChinaCandidate:C XuFull Text:PDF
GTID:2404330590466261Subject:Traditional Chinese Medicine
Abstract/Summary:PDF Full Text Request
Objective: To observe the clinical efficacy and safety of Qianjinweijing Decoction and Shengmai Powder on postoperative rehabilitation of non-small cell lung cancer patients with phlegm and blood stasis and qi and yin deficiency.Methods: According to the inclusion and exclusion criteria of this study,61 patients in the Department of Oncology and Cardiothoracic Surgery of the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine from February 2017 to March 2019.30 patients in the treatment group and 31 patients in the control group.The control group: pulmonary functional exercise.On the basis of the control group,the treatment group took Qianjinweijing Decoction and Shengmai Powder.Clinical efficacy and safety were evaluated from KPS scores,Cough symptom score,body weight,TCM syndrome,leukocyte and adverse events.Results: According to the data analysis: 1.There was significant difference in KPS scores between the treatment group and the control group after treatment(P<0.05).2.There was a statistically significant difference in body weight between the treatment group and the control group after treatment(P <0.05).3.There was a statistically significant difference in the reduction of cough symptom scores(daytime scores,nighttime scores,and total scores)between the treatment group and the control group(P <0.05).4.Compared the TCM syndrome scores between the treatment group and the control group,the treatment group was superior to the control group(P <0.05),Especially in cough,sputum,shortness of breath,chest pain,fatigue,dry mouth,dryness,spontaneous sweating and sweating.5.The changes of white blood cells in the treatment group and the control group were decreased,The effect of the treatment group was better than that of the control group(P<0.05).There were statistical differences.6.Safety indicators showed that only a few patients had symptoms ofdiarrhea,indicated the good safety.Conclusion: Qianjinweijing Decoction and Shengmai Powder can improve postoperative KPS score,reduce Cough symptom score and TCM syndrome,increase body weight and reduce white blood cell level,have good postoperative rehabilitation for patients with non-small cell lung cancer with phlegm and blood stasis and qi and yin deficiency.
Keywords/Search Tags:Qianjinweijing Decoction and Shengmai Powder, postoperative rehabilitation of non-small cell lung cancer, clinical observation
PDF Full Text Request
Related items
Clinical Observation Of Modified Bufei Decoction On Postoperative Rehabilitation Of Non-small Cell Lung Cancer With Deficiency Of Lung Qi
Clinical Study On Maintenance Treatment Of Advanced Non - Small Cell Lung Cancer By Traditional Chinese Medicine
Symptom Survey Of Postoperative Patients With Non-small Cell Lung Cancer And Clinical Research On Comprehensive Rehabilitation Of Traditional Chinese Medicine
Clinical Observation Of Bufei Tongbai Decoction In Treating Postoperative Lung Cancer-associated Cough(Lung Qi Deficiency Type) In Patients With Non-small Cell Lung Cancer
Clinical Observation Of Two Winter Decoction Combined With The Treatment Of Non Small Cell Lung Cancer With Advanced Yin Deficiency And Phlegm Heat
Clinical Observation Of Baihe Gujin Decoction And Shengmai Powder In The Treatment Of Chronic Obstructive Pulmonary Disease With Lung-kidney Qi-yin Deficiency Syndrome
The Clinical Observation Of ShenqiDihuang Decoction Combied With Shengmai Powder On Heart-Kindey Qi And Yin Deficiency Syndrome Of Chronic Renal Failure
Clinical Observation On The Therapeutic Effect Of Bufei Decoction Combined With Chemotherapy And Immunotherapy In The Treatment Of Advanced Non-small Cell Lung Cancer With Lung Qi Deficiency Syndrom
Postoperative Radiotherapy Associated Clinical Investigation In Non-small Cell Lung Cancer Treatment Outcomes And Prognosis For Masaoka Stage â…¢ Thymoma
10 Icotinib Combined With Shengmai Capsule In The Treatment Of Advanced Non-small Cell Lung Cancer